ASIC plays with insurance populism
ASIC is creating a jackpot of claims payouts at the cost of an unsustainable private disability insurance market.
Genetic testing set to trigger more insurance claims
Even a small increase in the level of genetic testing could lead to a double-digit rise in life insurance claims, reducing the profitability of life insurers unless they are able to raise premiums.
Insurers not weeping at WannaCry
Publicity from the latest cyber attack underlines how the value of cyber insurance is expected to grow exponentially even as premiums stagnate elsewhere.
AMP makes a patchy recovery
AMP's life arm comes back from dead, but the same can't be said for its superannuation business.
AXA plans IPO for US insurance, asset management
​French insurer AXA plans an IPO for its majority stake in AllianceBernstein and its US life insurance business.
Turnbull baulks at QLD government mutual
The insurance industry has dodged a bullet on a government-funded mutual for cyclones in North Queensland.
ANZ Wealth auction and the $9.5 billion smoking gun
ANZ Banking Group has hopes for its up-for-sale wealth unit.
QBE hunts for the practical in fintech rush
QBE doesn't have a sweet tooth when it comes to it tech spend.
QBE wants execs to have more skin in the game
QBE executives will now be required to own more shares in the insurer.
Don't demonise low-deposit loans, says Genworth
Lending to borrowers with small deposits can be done safely, says Genworth.
